NCT04104178View on ClinicalTrials.gov

Optimal Treatment of MRSA Throat Carriers

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

September 18, 2025

Study Completion Date

September 18, 2025

Conditions

MRSAMRSA Colonization

Interventions

DRUG

Clindamycin

Investigating whether a significantly higher number of MRSA throat carriers succeed in becoming MRSA free, when using Clindamycin on top of our general recommended topical treatment of Mupirocin nasal ointment + chorhexidin baths

DRUG

Placebo

Trial Locations (1)

Unknown

Hvidovre Hospital, Hvidovre

All Listed Sponsors

lead

Hvidovre University Hospital

OTHER

NCT04104178 - Optimal Treatment of MRSA Throat Carriers | Biotech Hunter | Biotech Hunter